Is there a role for tissue plasminogen activator (tPA) as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome (ARDS)? - Moore, H B; Barrett, C D; Moore, E E (J Trauma Acute Care Surg, 2020)
(e-pub ahead of print)